Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

BACKGROUND AND PURPOSE: Chronic kidney disease with reduced estimated glomerular filtration rate or elevated albuminuria increases risk for ischemic and hemorrhagic stroke. This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke and atrial fibrillation/flutter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zien, Jardine, Meg J., Li, Qiang, Neuen, Brendon L., Cannon, Christopher P., de Zeeuw, Dick, Edwards, Robert, Levin, Adeera, Mahaffey, Kenneth W., Perkovic, Vlado, Neal, Bruce, Lindley, Richard I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078131/
https://www.ncbi.nlm.nih.gov/pubmed/33874750
http://dx.doi.org/10.1161/STROKEAHA.120.031623

Ejemplares similares

Ejemplares similares